I am not a holder... but in absence of any clarification on the results and assuming they do hold, coupled with the fact that they will need to raise fund for phase 3 (assuming they get FDA approval)....my view of the valuation is that it's still expensive given ASX valuations....
again assuming results are what they are, is there a specific reason why everyone expects SP to go back up? I have seen many examples where emotions get better of investors and they throw around crazy valuations.....
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-484
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |